We are live on ! Find out more
AAP

Arax Advisory Partners Portfolio holdings

AUM $3.54B
1-Year Est. Return 19.14%
This Fund
S&P 500
This Quarter Est. Return
-1.19%
1 Year Est. Return
+19.14%
3 Year Est. Return
+47.9%
5 Year Est. Return
+48.74%
10 Year Est. Return
AUM
$1.56B
AUM Growth
-$29.8M
Cap. Flow
-$341K
Cap. Flow %
-0.02%
Top 10 Hldgs %
25.81%
Holding
3,122
New
704
Increased
853
Reduced
892
Closed
464

Sector Composition

Rank Sector Weight
1 Technology 5.41%
2 Financials 3.2%
3 Healthcare 2.44%
4 Consumer Discretionary 2.3%
5 Industrials 1.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMBA icon
2501
Ambarella
AMBA
$3.68B
$604 ﹤0.01%
+12
New +$821
BCO icon
2502
Brink's
BCO
$4.65B
$604 ﹤0.01%
7
-135
-95% -$12.2K
CRNX icon
2503
Crinetics Pharmaceuticals
CRNX
$8.9B
$604 ﹤0.01%
18
+12
+200% +$448
PFSI icon
2504
PennyMac Financial
PFSI
$4B
$601 ﹤0.01%
6
-38
-86% -$3.9K
RDNT icon
2505
RadNet
RDNT
$5.36B
$597 ﹤0.01%
+12
New +$710
USNA icon
2506
Usana Health Sciences
USNA
$275M
$594 ﹤0.01%
+22
New +$697
WVVI icon
2507
Willamette Valley Vineyards
WVVI
$12M
$594 ﹤0.01%
100
EMNT icon
2508
PIMCO Enhanced Short Maturity Active ESG ETF
EMNT
$211M
$593 ﹤0.01%
+6
New +$592
DFH icon
2509
Dream Finders Homes
DFH
$1.27B
$587 ﹤0.01%
+26
New +$608
FLNC icon
2510
Fluence Energy
FLNC
$1.75B
$587 ﹤0.01%
+121
New +$1.16K
SHOO icon
2511
Steven Madden
SHOO
$3.53B
$587 ﹤0.01%
22
-175
-89% -$6.16K
AGIO icon
2512
Agios Pharmaceuticals
AGIO
$1.91B
$586 ﹤0.01%
20
-62
-76% -$2.06K
AZZ icon
2513
AZZ Inc
AZZ
$4.53B
$586 ﹤0.01%
7
-170
-96% -$15.2K
BEAM icon
2514
Beam Therapeutics
BEAM
$2.81B
$586 ﹤0.01%
30
DNTH icon
2515
Dianthus Therapeutics
DNTH
$6.15B
$581 ﹤0.01%
32
FOLD
2516
DELISTED
Amicus Therapeutics
FOLD
$580 ﹤0.01%
71
+45
+173% +$416
VREX icon
2517
Varex Imaging
VREX
$516M
$580 ﹤0.01%
50
-33
-40% -$436
FRSH icon
2518
Freshworks
FRSH
$3.2B
$579 ﹤0.01%
41
GHM icon
2519
Graham Corp
GHM
$1.23B
$577 ﹤0.01%
+20
New +$759
RIGL icon
2520
Rigel Pharmaceuticals
RIGL
$733M
$576 ﹤0.01%
32
-53
-62% -$1.07K
CTLP
2521
DELISTED
Cantaloupe
CTLP
$575 ﹤0.01%
+73
New +$648
DBRG icon
2522
DigitalBridge
DBRG
$2.95B
$574 ﹤0.01%
+65
New +$683
FIP icon
2523
FTAI Infrastructure
FIP
$479M
$571 ﹤0.01%
+126
New +$787
SPXL icon
2524
Direxion Daily S&P 500 Bull 3x ETF
SPXL
$7.29B
$568 ﹤0.01%
+4
New +$668
CTOS icon
2525
Custom Truck One Source
CTOS
$2.52B
$566 ﹤0.01%
+134
New +$647

Similar funds

Arax Advisory Partners's Q1 2025 Portfolio in Review

As of Q1 2025, Arax Advisory Partners held 3,122 positions worth $1.56B, down 1.9% from $1.59B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Arax Advisory Partners's Q1 2025 filing shows 704 new, 853 increased, 892 reduced and 464 closed positions. Its largest new stake was Avantis Core Fixed Income ETF: 645,396 shares worth $26.7M. The largest sale was Dimensional Core Fixed Income ETF, an estimated $25.2M.

By sector, the portfolio is most concentrated in Technology at 5.4% of assets, down from 5.9% a quarter earlier, followed by Financials and Healthcare.

  • Arax Advisory Partners's largest Q1 2025 buy was Avantis Core Fixed Income ETF: 645,396 shares worth $26.7M.
  • Arax Advisory Partners added most to State Street SPDR Bloomberg 1-3 Month T-Bill ETF in Q1 2025, an estimated $21.8M increase.
  • Arax Advisory Partners's biggest Q1 2025 reduction was Dimensional Core Fixed Income ETF, cutting an estimated $25.2M.
  • Arax Advisory Partners fully exited Berkshire Hathaway Class B in Q1 2025, selling an estimated $1.03M.
  • Arax Advisory Partners's ten largest holdings make up 26% of its $1.56B portfolio in Q1 2025.
  • Arax Advisory Partners opened 704 new positions and closed 464 in Q1 2025.
  • Arax Advisory Partners's portfolio value fell 1.9% quarter-over-quarter to $1.56B.

Based on Arax Advisory Partners's 13F filing for Q1 2025, filed 15 May 2025.